Irene Helen Mannering, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4814 Sparks Blvd, Sparks, NV 89436 Phone: 753-240-6997 Fax: 775-323-6814 |
Dr. James A Torok, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2345 E Prater Way, #205, Sparks, NV 89434 Phone: 775-331-2882 Fax: 775-331-2976 |
Dr. Michael Riley Heaphy Jr., M.D. Dermatology - Dermatopathology Medicare: Accepting Medicare Assignments Practice Location: 4814 Sparks Blvd, Sparks, NV 89436 Phone: 775-324-0699 Fax: 775-323-6814 |
Jonathan Patrick Staidle, M.D. Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4814 Sparks Blvd, Sparks, NV 89436 Phone: 775-327-0699 Fax: 775-451-7501 |
Dr. Samantha Lynn Schneider, MD Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5050 Vista Blvd Unit 102, Sparks, NV 89436 Phone: 775-451-3376 |
News Archive
The Los Angeles Society of Pathologists, Inc. presented its Lifetime Achievement Award to Samuel W. French, MD, a principal investigator at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, on Jan. 15.
Physicians of Indian origin from across the globe congregated at the third annual conference of Global Association of Physicians of Indian Origin (GAPIO) in Kochi, Kerala, with a vision to improve healthcare worldwide from 1st to 3rd January 2013. GAPIO was launched in January 2011 to bring together 1.2 million physicians of Indian origin in the world on one professional platform. This substantial workforce of physicians is a valuable resource, which can help to mobilize significant developments in the healthcare globally. GAPIO already has representation from 15 countries in the President's Council.
Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices' recommendation for a booster shot of the Pfizer-BioNTech COVID-19 vaccine in certain populations and also recommended a booster dose for those in high risk occupational and institutional settings.
Cellectis S.A., the French genome engineering specialist, has announced that the European Patent Office has today upheld European Patent EP 1 485 475 owned by Cellectis and relating to the invention of engineering methods for meganucleases. This method is based on the genetic fusion of meganuclease modules to obtain hybrid meganucleases.
› Verified 2 days ago